Cote d'Ivoire vs Oman: Cause of death, by non-communicable diseases, ages 15-59
Cote d'Ivoire
42.6%
in 2021
Oman
41.8%
in 2021
Cote d'Ivoire rank
142nd
Oman rank
145th
Cause of death, by non-communicable diseases, ages 15-59 over time
- Cote d'Ivoire
- Oman
How they compare
Cote d'Ivoire currently reports 42.6% against 41.8% in Oman, a difference of 0.8%.
The two have swapped places 1 time across 6 shared years of data; in 2000 it was Oman ahead.
Cote d'Ivoire ranks 142nd and Oman ranks 145th of 185 countries.
Oman has averaged higher in every one of the 3 decades both report.
Head to head by decade
| Decade | Cote d'Ivoire | Oman | Difference | Ahead |
|---|---|---|---|---|
| 2000s | 15.3% | 67.5% | 52.2% | Oman |
| 2010s | 35.7% | 65.5% | 29.8% | Oman |
| 2020s | 42.2% | 50.8% | 8.5% | Oman |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher cause of death, by non-communicable diseases, ages 15-59, Cote d'Ivoire or Oman?
- Cote d'Ivoire, at 42.6% against 41.8% in Oman as of 2021.
- What is the difference in cause of death, by non-communicable diseases, ages 15-59 between Cote d'Ivoire and Oman?
- 0.8%, with Cote d'Ivoire ahead.
- How many years of comparable data are there for Cote d'Ivoire and Oman?
- 6 years are reported by both, from 2000 to 2021.
- How do Cote d'Ivoire and Oman rank globally for cause of death, by non-communicable diseases, ages 15-59?
- Cote d'Ivoire ranks 142nd and Oman ranks 145th of 185 countries.
- Where does this data come from?
- Global Health Estimates, World Health Organization (WHO), published as Cause of death, by non-communicable diseases, ages 15-59 (% of total deaths ages 15-59). Statizoid refreshes it automatically from the source and publishes the full history for both places.
Individual pages
About this data
Number of deaths ages 15-59 due to non-communicable diseases divided by number of all deaths ages 15-59 expressed by percentage. Non-Communicable diseases include cancer, diabetes mellitus, cardiovascular diseases, digestive diseases, skin diseases, musculoskeletal diseases, and congenital anomalies.